Globus Medical (GMED) Total Non-Current Liabilities (2011 - 2026)
Globus Medical's (GMED) quarterly Total Non-Current Liabilities came in at $700.6 million in Q2 2026, up 8.9% on a YoY basis from $643.3 million in Q2 2025, and up 2.03% quarter-over-quarter from $686.7 million in Q1 2026.
Analysis
Globus Medical (GMED) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
Globus Medical (GMED) has reported Total Non-Current Liabilities for 16 consecutive years, with $700.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities rose 8.9% year-over-year to $700.6 million; the trailing twelve-month figure through Jun 2026 stood at $700.6 million (up 8.9% YoY), and the FY2025 full-year result was $708.2 million, down 32.74% from the prior year.
- Total Non-Current Liabilities advanced to $700.6 million in Q2 2026 per GMED's latest filing, from $686.7 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $1.1 billion in Q3 2023 and bottomed at $199.8 million in Q3 2022.
- Historically, Total Non-Current Liabilities has averaged $639.7 million across 5 years, with a median of $679.2 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities jumped 473.67% in 2023, then plunged 40.11% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $219.4 million in 2022, then jumped by 384.73% to $1.1 billion in 2023, then fell by 1.0% to $1.1 billion in 2024, then sank by 32.74% to $708.2 million in 2025, then slipped by 1.07% to $700.6 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $700.6 million, $686.7 million, and $708.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Globus Medical | 9.98 Bn | 9.38 Bn | 548.17 Mn | 700.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 700.61 Mn |
| Mar 31, 2026 | 686.67 Mn |
| Dec 31, 2025 | 708.17 Mn |
| Sep 30, 2025 | 671.73 Mn |
| Jun 30, 2025 | 643.34 Mn |
| Mar 31, 2025 | 597.59 Mn |
| Dec 31, 2024 | 1.05 Bn |
| Sep 30, 2024 | 993.66 Mn |
| Jun 30, 2024 | 992.22 Mn |
| Mar 31, 2024 | 997.75 Mn |
| Dec 31, 2023 | 1.06 Bn |
| Sep 30, 2023 | 1.15 Bn |
| Jun 30, 2023 | 212.97 Mn |
| Mar 31, 2023 | 221.40 Mn |
| Dec 31, 2022 | 219.41 Mn |
| Sep 30, 2022 | 199.80 Mn |
| Jun 30, 2022 | 204.22 Mn |
| Mar 31, 2022 | 201.80 Mn |
| Dec 31, 2021 | 203.23 Mn |
| Sep 30, 2021 | 176.43 Mn |